Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. - Wikidata - wikimedia - TriplyDB

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

http://www.wikidata.org/entity/Q44632723

about

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease.Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States.Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection.De novo malignancies after liver transplantation: a major cause of late death.Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant.Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.Posttransplant lymphoproliferative disease in liver transplant patients.Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease.Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis.Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation.

P2860

Q26748580-4381CECE-B0D0-4E30-83A7-E19ED70F6C2F Q26780262-A0D6E7D5-EB9B-45B4-9D23-FF3213F1BC99 Q30303135-5230EEE1-2B75-4E4D-A65E-076D55F4F349 Q34120969-744A522E-2D83-479B-9C98-98DCDC3C6DE4 Q34294938-7417ABAC-4F58-4457-82A2-83201A9ADEE8 Q34426430-DA0D9819-C160-4AB9-ABD8-060CBBE6B4EA Q34630784-6E88C5D3-6F17-40BB-A7A0-A98221B86F4D Q36447876-DD4275E1-ACF2-42C5-B6F5-F82498B53BAC Q37838795-92BFDBCA-E7E9-4F8E-8477-6072725CBFB2 Q37845384-2795C101-47D1-4705-B65A-1A1DD710A718 Q42016255-EEA8B240-E4E3-40AE-858F-CF0147FBE5E0 Q43038855-B68BF47A-803C-474F-B7B4-32B5E279115D Q44454943-F0B36C33-716A-4C97-82EC-59C7181E5AF2 Q45509091-BF0D4B04-AB33-4F28-B2C8-4AA27CCD0061 Q46313524-50B4096D-EB17-4107-95D5-A09181E65BE3

P2860

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

http://www.wikidata.org/entity/Q44632723

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@en

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@nl

type

label

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@en

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@nl

prefLabel

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@en

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@nl

P1433

Q44632723-73A1A1B6-8AF0-447C-B829-BC8E08D10400

P1476

Q44632723-5AD5EC4D-4599-4ADF-84CE-9BA7491EDE0E

P2093

Q44632723-113F04EC-980B-4E06-A549-90A3A88004C4

Q44632723-222C6830-4E68-4059-9E80-3DE32690A823

Q44632723-446914D2-4AA2-47F1-96EF-D5FD25E632AE

Q44632723-4BCCB941-79A4-47F9-AC85-5C3EA81F2407

Q44632723-4EF62E35-D397-4622-A439-C06F5B46865B

Q44632723-795C8C65-6275-4CD1-9559-CEB3880D0BF2

Q44632723-C8AFC916-71CD-4479-81E2-3E8F948A43E5

Q44632723-E7546941-BF2B-405C-A10F-D09572E133BC

P2860

Q44632723-193DE681-F551-43D2-BCFC-19E099551F5D

Q44632723-30BD4387-5A55-48A8-933F-EA21FDE46B5A

Q44632723-56C4960D-1102-4E76-8B29-5A949361E6E2

Q44632723-6216D4BF-7F42-4067-9A6A-89ADDB3F6506

Q44632723-A5224835-DC3A-4A83-8305-3179A98B14E0

Q44632723-ACC2D86A-1136-40F3-9A66-EDFE74592C11

Q44632723-B99F2CCE-ACEB-4D57-BEC3-01C0BA5A8D31

Q44632723-D50D82AD-15B8-4C25-9F43-CF92BA2DA876

Q44632723-F0496EE6-69E4-4833-A9A3-3199CB6FF256

Q44632723-FE0CBD01-CB04-4102-8561-80E1D899C1DC

P304

Q44632723-945C16C1-3297-4EDF-A79D-9FBA8E4F5FB0

P31

Q44632723-52F7C091-A95E-427E-8773-11A9920CA014

P356

Q44632723-18C30634-7F99-4AF9-8A4C-413B557A8441

P407

Q44632723-90BA4454-ACF1-46BF-B5D9-8A98AC1D663B

P433

Q44632723-F34C1A3F-F07A-48C0-B528-16C25A79A5B2

P478

Q44632723-3D35E0B1-D996-4EA9-91E4-6C42299F3B2F

P50

Q44632723-EE92E33D-1420-4439-B8F1-158758FCB6DF

P577

Q44632723-5E8F90A8-C1D9-4D02-A8BF-FC6C91AEF190

P5875

Q44632723-80641C7B-063B-4D49-8610-E68F7D52AB65

P698

Q44632723-A05E9956-9263-4B73-B2D8-FD1F9B13BA1F

P921

Q44632723-C417E9F8-75BF-4291-A1ED-2E2C307225C3

P356

P1433

P1476

Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation.

@en

P2093

Cherqui D

http://www.w3.org/2001/XMLSchema#string

Dhumeaux D

http://www.w3.org/2001/XMLSchema#string

Duvoux C

http://www.w3.org/2001/XMLSchema#string

Gaulard P

http://www.w3.org/2001/XMLSchema#string

Germanidis G

http://www.w3.org/2001/XMLSchema#string

Hézode C

http://www.w3.org/2001/XMLSchema#string

Roudot-Thoraval F

http://www.w3.org/2001/XMLSchema#string

Vincens AL

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

The spectrum of extrahepatic manifestations in hepatitis C virus infection.

Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies.

Epstein-Barr virus and its possible role in the pathogenesis of B-cell lymphomas.

Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective.

Hepatitis C virus-related lymphomas.

Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation.

Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein.

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

P304

775-778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.510300314

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Pawlotsky

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228056375

http://www.w3.org/2001/XMLSchema#string

P698

10462385

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation